Nicardipine HCl 0.1mg/mL, 0.2mg/mL; soln for slow IV infusion. Angina. Heart failure. Acute cerebral infarction or hemorrhage. Hepatic or renal impairment. Pheochromocytoma. For caps: measure bloo ...

An AP-rated and therapeutically equivalent generic of Cardene IV (Chiesi) has been made available by American Regent. An AP-rated and therapeutically equivalent generic of Cardene IV (Chiesi ...

BEDMINSTER, N.J.--(BUSINESS WIRE)-- Results from the CLUE study, a head-to-head comparison between Ready-to-Use Cardene ® I.V. (nicardipine) and labetalol in the emergency room, showed that Ready ...

The Company markets a ready to use injectable formulation of 0.1 mg/ml and 0.2 mg/ml nicardipine hydrochloride in 0.86% and 0.83% sodium chloride under the name CARDENE ® I.V. (nicardipine ...

The product, which is a generic of EKR Therapeutics’ Cardene, is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. "American ...

The twist here is that PDL originally acquired one of those drugs, a high blood-pressure treatment called Cardene, when it purchased another specialty pharma called ESP Pharmaceuticals in early 2005.

IQVIATM sales data for the 12-month period ending October 2022 shows that the Cardene® Capsules achieved annual sales of approximately $10.9 million. According to IQVIATM sales data for the 12 ...